DENTSPLY SIRONA Inc. (NASDAQ:XRAY) went down by -0.34% from its latest closing price compared to the recent 1-year high of $65.09. The company’s stock price has collected 0.63% of gains in the last five trading sessions. Press Release reported 12 hours ago that Dentsply Sirona to Host First Quarter 2021 Conference Call on May 6th
Is It Worth Investing in DENTSPLY SIRONA Inc. (NASDAQ :XRAY) Right Now?
Plus, the 36-month beta value for XRAY is at 0.93. Opinions of the stock are interesting as 9 analysts out of 16 who provided ratings for DENTSPLY SIRONA Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 5 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $65.47, which is $2.27 above the current price. XRAY currently public float of 217.79M and currently shorts hold a 1.46% ratio of that float. Today, the average trading volume of XRAY was 1.60M shares.
XRAY’s Market Performance
XRAY stocks went up by 0.63% for the week, with a monthly jump of 3.30% and a quarterly performance of 15.64%, while its annual performance rate touched 69.47%. The volatility ratio for the week stands at 1.81% while the volatility levels for the past 30 days are set at 2.31% for DENTSPLY SIRONA Inc.. The simple moving average for the period of the last 20 days is 2.34% for XRAY stocks with a simple moving average of 27.04% for the last 200 days.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Barrington Research repeating the rating for XRAY by listing it as a “Outperform.” The predicted price for XRAY in the upcoming period, according to Barrington Research is $71 based on the research report published on March 02nd of the current year 2021.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $60, previously predicting the price at $55. The rating they have provided for XRAY stocks is “Neutral” according to the report published on March 02nd, 2021.
H.C. Wainwright gave a rating of “Neutral” to XRAY, setting the target price at $55 in the report published on January 05th of the current year.
XRAY Trading at 9.50% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.77% of loss for the given period.
Volatility was left at 2.31%, however, over the last 30 days, the volatility rate increased by 1.81%, as shares surge +6.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.16% upper at present.
During the last 5 trading sessions, XRAY rose by +0.63%, which changed the moving average for the period of 200-days by +46.58% in comparison to the 20-day moving average, which settled at $62.68. In addition, DENTSPLY SIRONA Inc. saw 22.12% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at XRAY starting from BRANDT ERIC, who sale 7,600 shares at the price of $63.21 back on Mar 17. After this action, BRANDT ERIC now owns 30,531 shares of DENTSPLY SIRONA Inc., valued at $480,373 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY SIRONA Inc., purchase 5,000 shares at $58.95 during a trade that took place back on Mar 04, which means that LUCIER GREGORY T is holding 23,142 shares at $294,750 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- +8.32 for the present operating margin
- +50.72 for the gross margin
The net margin for DENTSPLY SIRONA Inc. stands at -2.48. The total capital return value is set at 3.94, while invested capital returns managed to touch -1.21. Equity return is now at value -1.70, with -1.00 for asset returns.
Based on DENTSPLY SIRONA Inc. (XRAY), the company’s capital structure generated 49.43 points at debt to equity in total, while total debt to capital is 33.08. Total debt to assets is 26.28, with long-term debt to equity ratio resting at 42.44. Finally, the long-term debt to capital ratio is 28.40.
When we switch over and look at the enterprise to sales, we see a ratio of 4.04, with the company’s debt to enterprise value settled at 0.18. The receivables turnover for the company is 4.48 and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.